Home -> Law Blog Directory -> Personal Injury Law Blogs -> Bodily Injury Blog
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Personal Injury Law
: Bodily Injury BlogTwo Whistleblower Suits Over Heart Drug
By Edward Bills
Two whistleblower lawsuits got backing from the federal government Thursday over claims that a Johnson & Johnson unit, Scios Inc., engaged in off-label marketing for one of its heart drugs. According to a statement issued by the Department of Justice, Scios aggressively marketed the heart failure drug Natrecor to patients with less severe conditions beginning soon after the drug was approved in 2001. The cases are U.S. ex rel Strom et al v. Scios Inc. and Johnson & Johnson and U.S. ex rel Smith v. Scios and Johnson & Johnson.
Full post as published by Bodily Injury Blog on February 20, 2009 (boomark / email).
Mitchell Report Summary
Report on Steroid Drug Use in Major League Baseball by Senator George Mitchell
Heart of Atlanta v United States
Supreme Court Decision: Civil Rights Act Protected by Interstate Commerce Clause
Bextra Product Recall
Find a Bextra Lawyer
Bextra Injury Risks
Bextra Increases Risk of Fatal Heart Attack
Digitek Recalled
the heart drug allegedly contains double the medication that it should
Qui Tam Whistleblower - Government Fraud - Qui Tam Lawsuit
Qui Tam Whistleblower alleging fraud against the government reported by an individual acting as a government whistleblower.
Police Whistleblower
Officer awarded $980,000 for whistleblower violations and retaliation.
Drug Manufacturer Rebates
Caremark Corp. agrees to pay $38.5 million settlement after convincing doctors to switch drug brands.
City and Mayor Whistleblower
Two officers awarded part of $8 million whistleblower settlement.
Paxil Heart Defects
alleging Paxil causes heart defects in newborns.

Washington Post article says government can't keep up with whistleblower suits
U.S. joins FCA suit against drug company accused of off-label marketing
Preparing for the Wave of Whistleblower Lawsuits
U.S. Regulators Sue to Shut Down Heart Drug Manufacturer








